David I. Rhodes

1.4k citations

31 papers · 1.1k indexed · h-index 17

Virology top 1%
- HIV Research and Treatment 15
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 14
Immunology
Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis 4
Microbiology top 10%
- Antimicrobial Peptides and Activities 5
Molecular Biology
- Biochemical and Molecular Research 9
- Chemical Synthesis and Analysis 6
- Biochemical and Structural Characterization 3
Biomaterials
- Electrospun Nanofibers in Biomedical Applications 3

Co-authors: B.A. Stone John Deadman Nicholas J. Deacon Lesley J. Ashton Ajantha Solomon Jonathan A. Coates John S. Sullivan Jennifer C. Learmont
Cited by: Virology Infectious Diseases Immunology
Journals: New England Journal of Medicine (1 paper)PLoS ONE (2 papers)Journal of Virology (2 papers)
Partner nations: Australia China United States

In The Last Decade

David I. Rhodes

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by David I. Rhodes

Since Specialization

Citations

This map shows the geographic impact of David I. Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Rhodes more than expected).

Fields of papers citing papers by David I. Rhodes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Rhodes. The network helps show where David I. Rhodes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David I. Rhodes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David I. Rhodes Line = papers co-authored together David I. Rhodes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nerve guidance conduit development for primary treatment of peripheral nerve transection injuries: A commercial perspective Acta Biomaterialia ·Bradyn J. Parker,David I. Rhodes,Carmel O’Brien,Andrew E. Rodda,Neil R. Cameron	2021	73
2	Bioactive glycosides from the African medicinal plantBoerhavia erectaL. Natural Product Research ·Ari Satia Nugraha,Adama Hilou,Nicholas Vandegraaff,David I. Rhodes,Rachada Haritakun,Paul A. Keller	2015	14
3	Binaphthyl-anchored antibacterial tripeptide derivatives with hydrophobic C-terminal amino acid variations Beilstein Journal of Organic Chemistry ·John B. Bremner,Paul A. Keller,Stephen G. Pyne,Mark J. Robertson,K. Sakthivel,Kittiya Somphol,Dean Baylis,Jonathan A. Coates,John Deadman,Dharshini Jeevarajah,David I. Rhodes	2012	5
4	Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification? SLAS DISCOVERY ·J. Wielens,Stephen J. Headey,David I. Rhodes,Roger J. Mulder,Olan Dolezal,John Deadman,Janet Newman,David K. Chalmers,Michael W. Parker,Thomas S. Peat,M.J. Scanlon	2012	58
5	Synthesis and antibacterial activity of C2-symmetric binaphthyl scaffolded amino acid derivatives European Journal of Medicinal Chemistry ·Mark J. Robertson,John B. Bremner,Jonathan A. Coates,John Deadman,Paul A. Keller,Stephen G. Pyne,Kittiya Somphol,David I. Rhodes	2011	8
6	Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site ChemBioChem ·David I. Rhodes,Thomas S. Peat,Nick Vandegraaff,Dharshini Jeevarajah,Janet Newman,John C. Martyn,Jonathan A. Coates,Nicholas J. Ede,Philip A. Rea,John Deadman	2011	29
7	Synthesis and antibacterial activity of some binaphthyl-supported macrocycles containing a cationic amino acid Bioorganic & Medicinal Chemistry ·Daniel R. Coghlan,John B. Bremner,Paul A. Keller,Stephen G. Pyne,Dorothy M. David,Kittiya Somphol,Dean Baylis,Jonathan A. Coates,John Deadman,David I. Rhodes,Alan D. Robertson	2011	3
8	Fragment‐Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1 ChemMedChem ·J. Wielens,Stephen J. Headey,John Deadman,David I. Rhodes,Michael W. Parker,David K. Chalmers,M.J. Scanlon	2010	23
9	Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1 Bioorganic & Medicinal Chemistry ·John B. Bremner,Paul A. Keller,Stephen G. Pyne,Timothy P. Boyle,Zinka Brkić,Dorothy M. David,Mark J. Robertson,Kittiya Somphol,Dean Baylis,Jonathan A. Coates,John Deadman,Darshini Jeevarajah,David I. Rhodes	2010	19
10	Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents Bioorganic & Medicinal Chemistry Letters ·Ben Li,E. D. Jones,Enkun Zhou,Li Chen,Dean Baylis,Shanghai Yu,Miao Wang,Xing He,Jonathan Alan Victor Coates,David I. Rhodes,Gang Pei,John Deadman,Xin Xie,Dawei Ma	2010	6
11	Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses Bioorganic & Medicinal Chemistry Letters ·Giang Le,Nick Vandegraaff,David I. Rhodes,E. D. Jones,Jonathan A. Coates,Long Lü,Xinming Li,Changjiang Yu,Xiao Feng,John Deadman	2010	16
12	Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site FEBS Letters ·J. Wielens,Stephen J. Headey,Dharshini Jeevarajah,David I. Rhodes,John Deadman,David K. Chalmers,M.J. Scanlon,Michael W. Parker	2010	31
13	Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2 Bioorganic & Medicinal Chemistry ·John B. Bremner,Paul A. Keller,Stephen G. Pyne,Timothy P. Boyle,Zinka Brkić,Jody Morgan,Kittiya Somphol,Jonathan A. Coates,John Deadman,David I. Rhodes	2010	12
14	Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: Azoles: Effective metal chelators Bioorganic & Medicinal Chemistry Letters ·Giang Le,Nick Vandegraaff,David I. Rhodes,E. D. Jones,Jonathan A. Coates,Neeranat Thienthong,Lisa J. Winfield,Long Lü,Xinming Li,Changjiang Yu,Xiao Feng,John Deadman	2010	28
15	Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold Bioorganic & Medicinal Chemistry Letters ·E. D. Jones,Nick Vandegraaff,Giang Le,Neil Choi,William Issa,Katherine Macfarlane,Neeranat Thienthong,Lisa J. Winfield,Jonathan A. Coates,Long Lü,Xinming Li,Xiao Feng,Changjiang Yu,David I. Rhodes,John Deadman	2010	32
16	Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents Bioorganic & Medicinal Chemistry Letters ·Ben Li,E. D. Jones,Enkun Zhou,Chen Li,Dean Baylis,Shanghai Yu,Miao Wang,Xing He,Jonathan Alan Victor Coates,David I. Rhodes,Gang Pei,John Deadman,Xin Xie,Dawei Ma	2010	4
17	Binaphthyl scaffolded peptoids via ring-closing metathesis reactions and their anti-bacterial activities Bioorganic & Medicinal Chemistry Letters ·Adel Garas,John B. Bremner,Jonathan A. Coates,John Deadman,Paul A. Keller,Stephen G. Pyne,David I. Rhodes	2009	14
18	Hydroxycinnamic Acids in Walls of Wheat Aleurone Cells Journal of Cereal Science ·David I. Rhodes,M Sadek,B.A. Stone	2002	71
19	c-Myb Influences HIV Type 1 Gene Expression and Virus Production AIDS Research and Human Retroviruses ·Melissa J. Churchill,Robert G. Ramsay,David I. Rhodes,Nicholas J. Deacon	2001	8
20	Immunologic and Virologic Status after 14 to 18 Years of Infection with an Attenuated Strain of HIV-1 — A Report from the Sydney Blood Bank Cohort New England Journal of Medicine ·Jennifer C. Learmont,Andrew F. Geczy,John Mills,Lesley J. Ashton,Camille Raynes‐Greenow,Roger Garsia,Wayne B. Dyer,Larissa B. McIntyre,Robert Oelrichs,David I. Rhodes,Nicholas J. Deacon,Dale A. McPhee,Suzanne M. Crowe,Ajantha Solomon,Catherine Chatfield,Sean A. Blasdall,Harmjan Kuipers,John S. Sullivan	1999	255

About David I. Rhodes

David I. Rhodes is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers), Biochemical and Molecular Research (9 papers), Chemical Synthesis and Analysis (6 papers), Antimicrobial Peptides and Activities (5 papers), Carbohydrate Chemistry and Synthesis (4 papers), Biochemical and Structural Characterization (3 papers) and Electrospun Nanofibers in Biomedical Applications (3 papers). The work is most often cited by research in Virology (545 citations), Infectious Diseases (399 citations) and Immunology (192 citations). David I. Rhodes has collaborated with scholars based in Australia, China and United States. Frequent co-authors include B.A. Stone, John Deadman, Nicholas J. Deacon, Lesley J. Ashton, Ajantha Solomon, Jonathan A. Coates, John S. Sullivan, Jennifer C. Learmont, Nick Vandegraaff and Andrew E. Rodda. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact